Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.97 USD | -1.01% | +8.84% | -86.62% |
Apr. 11 | Baird Trims Amylyx Pharmaceuticals' Price Target to $3 From $4, Maintains Neutral Rating | MT |
Apr. 10 | Transcript : Amylyx Pharmaceuticals, Inc. - Special Call |
Financials (USD)
Sales 2024 * | 102M | Sales 2025 * | 167K | Capitalization | 134M |
---|---|---|---|---|---|
Net income 2024 * | -105M | Net income 2025 * | -84M | EV / Sales 2024 * | 0.81 x |
Net cash position 2024 * | 51.6M | Net cash position 2025 * | 168M | EV / Sales 2025 * | -206 x |
P/E ratio 2024 * |
-1.28
x | P/E ratio 2025 * |
-1.66
x | Employees | 384 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.13% |
Latest transcript on Amylyx Pharmaceuticals, Inc.
1 day | -1.01% | ||
1 week | +8.84% | ||
Current month | +8.84% | ||
1 month | -24.81% | ||
3 months | -86.97% | ||
6 months | -89.17% | ||
Current year | -86.62% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Klee
FOU | Founder | 34 | 12-12-31 |
Josh Cohen
FOU | Founder | 33 | 12-12-31 |
Jim Frates
DFI | Director of Finance/CFO | 56 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Milne
CHM | Chairman | 80 | 14-12-31 |
Kari Firestone
BRD | Director/Board Member | - | 23-03-15 |
Paul R. Fonteyne
BRD | Director/Board Member | 63 | 21-03-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.14% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | +3.48% | - | |
0.04% | 2 M€ | -.--% | ||
0.02% | 0 M€ | +8.42% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 1.97 | -1.01% | 900,905 |
24-05-06 | 1.99 | -1.97% | 1,527,305 |
24-05-03 | 2.03 | +1.50% | 1,478,023 |
24-05-02 | 2 | +3.63% | 1,911,403 |
24-05-01 | 1.93 | +6.63% | 1,803,267 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.62% | 134M | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
-15.40% | 31.87B | |
+52.53% | 24.52B | |
-14.35% | 15.68B | |
-39.65% | 12.23B | |
-6.52% | 12.34B | |
-13.41% | 12.21B | |
+5.54% | 8.83B |
- Stock Market
- Equities
- AMLX Stock